| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355802A Substituted porphyrins |
| 06/26/2002 | CN1355789A Indigoid bisindole derivatives |
| 06/26/2002 | CN1355708A HCV combination therapy containing ribavirin in association with antioxidants |
| 06/26/2002 | CN1355707A Use of interleukin-11 to treat hemorrhagic shock |
| 06/26/2002 | CN1355697A IL-8 receptor antagonists |
| 06/26/2002 | CN1355252A Hetergeneous product of bio-active protein and its preparing process |
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410733 Anticoagulants |
| 06/25/2002 | US6410684 Serine protease inhibitors |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410536 Anticoagulants |
| 06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410218 Plasma-like solution |
| 06/25/2002 | US6410054 Immediate release eplerenone compositions |
| 06/25/2002 | CA2136893C Substituted n-piperidino-pyrazole-3-carboxamide |
| 06/25/2002 | CA2094347C A method of producing a factor viii preparation |
| 06/25/2002 | CA2081659C Recombinant human factor viii derivatives |
| 06/21/2002 | CA2363799A1 Novel methods for using alkanoyloxymethyl esters |
| 06/21/2002 | CA2363758A1 Novel delta dicarbonyl compounds and methods for using same |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048194A1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/20/2002 | WO2002048180A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 06/20/2002 | WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047726A2 Pharmaceutical composition containing an active with a hemolytic action and a surfactant |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047677A1 Agents for ameliorating carbonyl stress |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002022571A3 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 06/20/2002 | WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY |
| 06/20/2002 | WO2001094613A3 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001037818A3 Medicament and combination of compatible medicaments |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | WO2000076451A3 Pharmaceutical composition comprising no or at least a no donor compound inducing no formation in cells |
| 06/20/2002 | US20020077579 Sterile bicarbonate-free dialysis concentrate solutions |
| 06/20/2002 | US20020077506 For therapy of inflammatory or painful disorder |
| 06/20/2002 | US20020077486 Platelet ADP receptor inhibitors |
| 06/20/2002 | US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis |
| 06/20/2002 | US20020077356 Nonsteroidal antiinflammatory agents |
| 06/20/2002 | US20020077344 For therapy and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, endothelial dysfunction |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | US20020077294 Method of treating blood disorders |
| 06/20/2002 | US20020076798 Liver-specific gene expression cassettes, and methods of use |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076445 Eukaryotic cells and method for preserving cells |
| 06/20/2002 | US20020076381 Novel compositions for use in embolizing blood vessels |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | DE10060292A1 Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibiting the Na + / H + exchanger and containing medicament |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/20/2002 | CA2365517A1 Sterile bicarbonate-free dialysis concentrate solutions |
| 06/20/2002 | CA2365494A1 Lawsonia intracellularis vaccine |
| 06/19/2002 | EP1215215A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 06/19/2002 | EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214323A1 Indoloazepines as vasopressin receptor antagonists |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1213965A1 Thrombopoietin mimetics |
| 06/19/2002 | EP0878201B1 Medicaments for the treatment or prevention of thrombocytopenia |
| 06/19/2002 | EP0772450B1 Methods for treating bleeding disorders |
| 06/19/2002 | CN1354673A New dialysis method |
| 06/19/2002 | CN1354669A Pharmaceutical compositions of erythropoietin |
| 06/19/2002 | CN1353987A Medicine for curing myeloproliferative abnormal syndrome |
| 06/18/2002 | US6407250 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407140 Autoimmune diseases, graft versus host disease and organ transplant surgery; pyrazole derivative mixture |
| 06/18/2002 | US6407070 Mixture containing granulation agent; therapy for kidney disease |
| 06/18/2002 | US6407067 Salts of thrombin inhibitors |
| 06/18/2002 | US6406839 Methods for using a plasma-like solution |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |